KALY Stock Overview
Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Kali, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 0% |
3 Year Change | -99.96% |
5 Year Change | -99.99% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
KALY | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | -0.3% | 0.5% |
1Y | 0% | 22.4% | 29.0% |
Return vs Industry: KALY underperformed the US Pharmaceuticals industry which returned 22.4% over the past year.
Return vs Market: KALY underperformed the US Market which returned 29% over the past year.
Price Volatility
KALY volatility | |
---|---|
KALY Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.5% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: KALY has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine KALY's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Frederick Ferri | https://www.kali-extracts.com |
Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses. It provides pharmaceuticals, cannabis extracts, and health and wellness products. The company was formerly known as VLOV Inc. and changed its name to Kali, Inc. in February 2016.
Kali, Inc. Fundamentals Summary
KALY fundamental statistics | |
---|---|
Market cap | US$1.54k |
Earnings (TTM) | US$20.66m |
Revenue (TTM) | US$105.99m |
0.0x
P/E Ratio0.0x
P/S RatioIs KALY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KALY income statement (TTM) | |
---|---|
Revenue | US$105.99m |
Cost of Revenue | US$60.18m |
Gross Profit | US$45.82m |
Other Expenses | US$25.16m |
Earnings | US$20.66m |
Last Reported Earnings
Mar 31, 2013
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did KALY perform over the long term?
See historical performance and comparison